Article
PD-L1 blockade immunotherapy rewires cancer emergency myelopoiesis
2023-12-21
Abstract excerpt
Immune checkpoint blockade (ICB) immunotherapy has revolutionized cancer treatment, demonstrating exceptional clinical responses in a wide range of cancers. Despite the success, a significant proportion of patients still fail to respond, highlighting the existence of unappreciated mechanisms of immunotherapy resistance. Delineating such mechanisms is paramount to minimize immunotherapy failures and optimize the cl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2c1cbe6b-6aef-5bd9-8a2b-dbd6388e214b
- DOI
- 10.1101/2023.12.20.572561
